The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness
Open accessAbstract
BACKGROUND: There are conflicting data on the effects of antipsychotic medications on delirium in patients in the intensive care unit (ICU). METHODS: In a randomized, double-blind, placebo-controlled trial, we assigned patients with acute respiratory failure or shock and hypoactive or hyperactive delirium to receive intravenous boluses of haloperidol (maximum dose, 20 mg daily), ziprasidone (maximum dose, 40 mg daily), or placebo. The volume and dose of a trial drug or placebo was halved or doubled at 12-hour intervals on the basis of the presence or absence of delirium, as detected with the use of the Confusion Assessment Method for the ICU, and of side effects of the intervention. The primary end point was the number of days alive without delirium or coma during the 14-day intervention period. Secondary end points included 30-day and 90-day survival, time to freedom from mechanical ventilation, and time to ICU and hospital discharge. Safety end points included extrapyramidal symptoms and excessive sedation. RESULTS: Written informed consent was obtained from 1183 patients or their authorized representatives. Delirium developed in 566 patients (48%), of whom 89% had hypoactive delirium and 11% had hyperactive delirium. Of the 566 patients, 184 were randomly assigned to receive placebo, 192 to receive haloperidol, and 190 to receive ziprasidone. The median duration of exposure to a trial drug or placebo was 4 days (interquartile range, 3 to 7). The median number of days alive without delirium or coma was 8.5 (95% confidence interval [CI], 5.6 to 9.9) in the placebo group, 7.9 (95% CI, 4.4 to 9.6) in the haloperidol group, and 8.7 (95% CI, 5.9 to 10.0) in the ziprasidone group (P=0.26 for overall effect across trial groups). The use of haloperidol or ziprasidone, as compared with placebo, had no significant effect on the primary end point (odds ratios, 0.88 [95% CI, 0.64 to 1.21] and 1.04 [95% CI, 0.73 to 1.48], respectively). There were no significant between-group differences with respect to the secondary end points or the frequency of extrapyramidal symptoms. CONCLUSIONS: The use of haloperidol or ziprasidone, as compared with placebo, in patients with acute respiratory failure or shock and hypoactive or hyperactive delirium in the ICU did not significantly alter the duration of delirium. (Funded by the National Institutes of Health and the VA Geriatric Research Education and Clinical Center; MIND-USA ClinicalTrials.gov number, NCT01211522 .).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Devlin, J. W., Skrobik, Y., Gélinas, C., Needham, D. M., Slooter, A. J. C., Pandharipande, P. P., Watson, P. L., Weinhouse, G. L., Nunnally, M. E., Rochwerg, B., et al. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003299 · Cited by 3,956
Self-citationSessler, C. N., Gosnell, M. S., Grap, M. J., Brophy, G. M., O'Neal, P. V., Keane, K. A., Tesoro, E. P., & Elswick, R. K. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2107138 · Cited by 3,695
A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS
SIMPSON, G. M., B., M., B., G., ANGUS, J. W. S., P., F. R. C., & M., D. P. (1970) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1970.tb02066.x · Cited by 3,264
Ely, E. W., Inouye, S. K., Bernard, G. R., Gordon, S., Francis, J., May, L., Truman, B., Speroff, T., Gautam, S., Margolin, R., et al. (2001) · JAMA · doi:10.1001/jama.286.21.2703 · Cited by 3,210
Self-citationDelirium as a Predictor of Mortality in Mechanically Ventilated Patients in the Intensive Care Unit
Ely, E. W. (2004) · JAMA · doi:10.1001/jama.291.14.1753 · Cited by 3,073
Self-citationLong-term cognitive impairment after critical illness
Pandharipande, P. P., Girard, T. D., Jackson, J. C., Morandi, A., Thompson, J. L., Pun, B. T., Brummel, N. E., Hughes, C. G., Vasilevskis, E. E., Shintani, A. K., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301372 · Cited by 2,842
Self-citationEly, E. W., Margolin, R., Francis, J., May, L., Truman, B., Dittus, R., Speroff, T., Gautam, S., Bernard, G. R., & Inouye, S. K. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00012 · Cited by 2,422
Self-citationGirard, T. D., Kress, J. P., Fuchs, B. D., Thomason, J. W., Schweickert, W. D., Pun, B. T., Taichman, D. B., Dunn, J. G., Pohlman, A. S., Kinniry, P. A., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60105-1 · Cited by 2,055
Self-citationEly, E. W., Truman, B., Shintani, A., Thomason, J. W. W., Wheeler, A. P., Gordon, S., Francis, J., Speroff, T., Gautam, S., Margolin, R., et al. (2003) · JAMA · doi:10.1001/jama.289.22.2983 · Cited by 1,707
Self-citationJorm, A. F. (1994) · Psychological Medicine · doi:10.1017/s003329170002691x · Cited by 1,204
Atypical antipsychotic drugs and the risk of sudden cardiac death
Ray, W. A., Chung, C. P., Murray, K. T., Hall, K., & Stein, C. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806994 · Cited by 1,194
Cognitive Trajectories after Postoperative Delirium
Saczynski, J. S., Marcantonio, E. R., Quach, L., Fong, T. G., Gross, A., Inouye, S. K., & Jones, R. N. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112923 · Cited by 1,188
Long-Term Cognitive Impairment After Critical Illness
Pandharipande, P. P., Girard, T. D., Jackson, J. C., Morandi, A., Thompson, J. L., Pun, B. T., Brummel, N. E., Hughes, C. G., Vasilevskis, E. E., Shintani, A. K., et al. (2014) · Survey of Anesthesiology · doi:10.1097/sa.0000000000000071 · Cited by 1,114
Self-citationPun, B. T., Balas, M. C., Barnes-Daly, M. A., Thompson, J. L., Aldrich, J. M., Barr, J., Byrum, D., Carson, S. S., Devlin, J. W., Engel, H. J., et al. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000003482 · Cited by 1,093
Self-citationThe impact of delirium in the intensive care unit on hospital length of stay
Ely, E., Gautam, S., Margolin, R., Francis, J., May, L., Speroff, T., Truman, B., Dittus, R., Bernard, G., & Inouye, S. (2001) · Intensive Care Medicine · doi:10.1007/s00134-001-1132-2 · Cited by 1,038
Self-citationDays of Delirium Are Associated with 1-Year Mortality in an Older Intensive Care Unit Population
Pisani, M. A., Kong, S. Y. J., Kasl, S. V., Murphy, T. E., Araujo, K. L. B., & Van Ness, P. H. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200904-0537oc · Cited by 798
Self-citationDelirium and its motoric subtypes: A study of 614 critically ill patients
Peterson, J. F., Pun, B. T., Dittus, R. S., Thomason, J. W. W., Jackson, J. C., Shintani, A. K., & Ely, E. W. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.00621.x · Cited by 660 · cited 1×
“of patients (%) 50 (27) 50 (26) 53 (28)”
Delirium in an intensive care unit: a study of risk factors
Dubois, M.-J., Bergeron, N., Dumont, M., Dial, S., & Skrobik, Y. (2001) · Intensive Care Medicine · doi:10.1007/s001340101017 · Cited by 609 · cited 2×
“Between admission and randomization 18 (10) 20 (10) 22 (12)”
BackgroundDevlin, J. W., Roberts, R. J., Fong, J. J., Skrobik, Y., Riker, R. R., Hill, N. S., Robbins, T., & Garpestad, E. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181b9e302 · Cited by 525
The ABCDEF Bundle: Science and Philosophy of How ICU Liberation Serves Patients and Families
Ely, E. W. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002175 · Cited by 514
Self-citationDelirium duration and mortality in lightly sedated, mechanically ventilated intensive care patients*
Shehabi, Y., Riker, R. R., Bokesch, P. M., Wisemandle, W., Shintani, A., & Ely, E. W. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181f85759 · Cited by 470
Self-citationGirard, T. D., Pandharipande, P. P., Carson, S. S., Schmidt, G. A., Wright, P. E., Canonico, A. E., Pun, B. T., Thompson, J. L., Shintani, A. K., Meltzer, H. Y., et al. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181c58715 · Cited by 451
Self-citationGirard, T. D., Thompson, J. L., Pandharipande, P. P., Brummel, N. E., Jackson, J. C., Patel, M. B., Hughes, C. G., Chandrasekhar, R., Pun, B. T., Boehm, L. M., et al. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30062-6 · Cited by 437
Self-citationBarnes-Daly, M. A., Phillips, G., & Ely, E. W. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002149 · Cited by 425
Self-citationPage, V. J., Ely, E. W., Gates, S., Zhao, X. B., Alce, T., Shintani, A., Jackson, J., Perkins, G. D., & McAuley, D. F. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70166-8 · Cited by 410
Self-citationDorman, T. (2011) · Yearbook of Critical Care Medicine · doi:10.1016/s0734-3299(10)79437-5 · Cited by 385
Ely, E. W., Stephens, R. K., Jackson, J. C., Thomason, J. W. W., Truman, B., Gordon, S., Dittus, R. S., & Bernard, G. R. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000098033.94737.84 · Cited by 359
Self-citationPatel, R. P., Gambrell, M., Speroff, T., Scott, T. A., Pun, B. T., Okahashi, J., Strength, C., Pandharipande, P., Girard, T. D., Burgess, H., et al. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819b8608 · Cited by 319
Self-citationMorandi, A., Piva, S., Ely, E. W., Myatra, S. N., Salluh, J. I. F., Amare, D., Azoulay, E., Bellelli, G., Csomos, A., Fan, E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002640 · Cited by 280
Self-citationContinuous infusion of haloperidol controls agitation in critically ill patients
RIKER, R. R., FRASER, G. L., & COX, P. M. (1994) · Critical Care Medicine · doi:10.1097/00003246-199403000-00013 · Cited by 262
Brummel, N. E., Girard, T. D., Ely, E. W., Pandharipande, P. P., Morandi, A., Hughes, C. G., Graves, A. J., Shintani, A., Murphy, E., Work, B., et al. (2014) · Intensive Care Medicine · doi:10.1007/s00134-013-3136-0 · Cited by 256
Self-citationBalas, M. C., Burke, W. J., Gannon, D., Cohen, M. Z., Colburn, L., Bevil, C., Franz, D., Olsen, K. M., Ely, E. W., & Vasilevskis, E. E. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182a17064 · Cited by 247
Self-citationShehabi, Y., Bellomo, R., Kadiman, S., Ti, L. K., Howe, B., Reade, M. C., Khoo, T. M., Alias, A., Wong, Y.-L., Mukhopadhyay, A., et al. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003071 · Cited by 239
Antipsychotics for treatment of delirium in hospitalised non-ICU patients
Burry, L., Mehta, S., Perreault, M. M., Luxenberg, J. S., Siddiqi, N., Hutton, B., Fergusson, D. A., Bell, C., & Rose, L. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005594.pub3 · Cited by 237
Wolters, A. E., van Dijk, D., Pasma, W., Cremer, O. L., Looije, M. F., de Lange, D. W., Veldhuijzen, D. S., & Slooter, A. J. (2014) · Critical Care · doi:10.1186/cc13929 · Cited by 198
The attributable mortality of delirium in critically ill patients: prospective cohort study
Klein Klouwenberg, P. M. C., Zaal, I. J., Spitoni, C., Ong, D. S. Y., van der Kooi, A. W., Bonten, M. J. M., Slooter, A. J. C., & Cremer, O. L. (2014) · BMJ · doi:10.1136/bmj.g6652 · Cited by 197
The Cost of ICU Delirium and Coma in the Intensive Care Unit Patient
Vasilevskis, E. E., Chandrasekhar, R., Holtze, C. H., Graves, J., Speroff, T., Girard, T. D., Patel, M. B., Hughes, C. G., Cao, A., Pandharipande, P. P., et al. (2018) · Medical Care · doi:10.1097/mlr.0000000000000975 · Cited by 165
Self-citationWoodward, N. D., Purdon, S. E., Meltzer, H. Y., & Zald, D. H. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.08.021 · Cited by 156
Use of High-Dose Intravenous Haloperidol in the Treatment of Agitated Cardiac Patients
Tesar, G. E., Murray, G. B., & Cassem, N. H. (1985) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198505060-00009 · Cited by 129
A national survey of the management of delirium in UK intensive care units
Sweeney, R. M., Barber, V. S., Page, V. J., Ely, E. W., Perkins, G. D., Young, D., & McAuley, D. F. (2010) · QJM · doi:10.1093/qjmed/hcp194 · Cited by 114
Self-citationEvaluation and Treatment of Agitation in the Intensive Care Unit
Tesar, G. E., & Stern, T. A. (1986) · Journal of Intensive Care Medicine · doi:10.1177/088506668600100304 · Cited by 42
Cited by
Wilson, J. E., Mart, M. F., Cunningham, C., Shehabi, Y., Girard, T. D., MacLullich, A. M. J., Slooter, A. J. C., & Ely, E. W. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00223-4 · Cited by 1,200
Self-citationPun, B. T., Badenes, R., Heras La Calle, G., Orun, O. M., Chen, W., Raman, R., Simpson, B.-G. K., Wilson-Linville, S., Hinojal Olmedillo, B., Vallejo de la Cueva, A., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30552-x · Cited by 522
Self-citationCOVID-19: ICU delirium management during SARS-CoV-2 pandemic
Kotfis, K., Williams Roberson, S., Wilson, J. E., Dabrowski, W., Pun, B. T., & Ely, E. W. (2020) · Critical Care · doi:10.1186/s13054-020-02882-x · Cited by 506
Self-citationSmith, H. A. B., Besunder, J. B., Betters, K. A., Johnson, P. N., Srinivasan, V., Stormorken, A., Farrington, E., Golianu, B., Godshall, A. J., Acinelli, L., et al. (2022) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000002873 · Cited by 505
Delirium in critical illness: clinical manifestations, outcomes, and management
Stollings, J. L., Kotfis, K., Chanques, G., Pun, B. T., Pandharipande, P. P., & Ely, E. W. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06503-1 · Cited by 446
Self-citation
Metadata
- Authors
- Girard, T. D., Exline, M. C., Carson, S. S., Hough, C. L., Rock, P., Gong, M. N., Douglas, I. S., Malhotra, A., Owens, R. L., Feinstein, D. J., Khan, B., Pisani, M. A., Hyzy, R. C., Schmidt, G. A., Schweickert, W. D., Hite, R. D., Bowton, D. L., Masica, A. L., Thompson, J. L., Chandrasekhar, R., Pun, B. T., Strength, C., Boehm, L. M., Jackson, J. C., Pandharipande, P. P., Brummel, N. E., Hughes, C. G., Patel, M. B., Stollings, J. L., Bernard, G. R., Dittus, R. S., & Ely, E. W.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2018-12-27
- Volume
- 379
- Issue
- 26
- Pages
- 2506-2516
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2896197442
- Cited by
- 573
- References
- 41
- FWCI
- 49.56
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.